Article
Are Oral Selective Estrogen Receptor Degraders Beneficial for Patients With ESR1-Mutated Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Oct 2024
Okeya Aoba, Shimomura Akihiko, Kitagawa Dai, Shimizu Chikako
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.